First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
In this podcast series, Mitchell | Genex subject matter experts from across the business share their expertise on how the COVID-19 pandemic is affe
As the United States continues to battle COVID-19, many states have taken emergency legislative and regulatory actions to address potential issues
As workplace violence rates in the retail and restaurant industries continue to rise, workers compensation experts say claims arising from su
A long-held belief exists that “the customer is always right” and whether or not you believe this to be accurate, we can likely agree that always b
Want to learn more about how your organization can manage the aging workforce, medication safety and cyber security?
The new decade has arrived and we are taking a look ahead at the regulatory and compliance trends we expect to hit the workers’ compensation market